Earnings Working Against Scientex Berhad's (KLSE:SCIENTX) Share Price

Scientex Berhad's (KLSE:SCIENTX) price-to-earnings (or "P/E") ratio of 9.5x might make it look like a buy right now compared to the market in Malaysia, where around half of the companies have P/E ratios above 14x and even P/E's above 25x are quite common. Although, it's not wise to just take the P/E at face value as there may be an explanation why it's limited.

Scientex Berhad hasn't been tracking well recently as its declining earnings compare poorly to other companies, which have seen some growth on average. It seems that many are expecting the dour earnings performance to persist, which has repressed the P/E. If you still like the company, you'd be hoping this isn't the case so that you could potentially pick up some stock while it's out of favour.

View our latest analysis for Scientex Berhad

pe-multiple-vs-industry
KLSE:SCIENTX Price to Earnings Ratio vs Industry July 21st 2025
If you'd like to see what analysts are forecasting going forward, you should check out our free report on Scientex Berhad.
Advertisement

What Are Growth Metrics Telling Us About The Low P/E?

Scientex Berhad's P/E ratio would be typical for a company that's only expected to deliver limited growth, and importantly, perform worse than the market.

If we review the last year of earnings, dishearteningly the company's profits fell to the tune of 2.4%. This has soured the latest three-year period, which nevertheless managed to deliver a decent 19% overall rise in EPS. Although it's been a bumpy ride, it's still fair to say the earnings growth recently has been mostly respectable for the company.

Shifting to the future, estimates from the seven analysts covering the company suggest earnings should grow by 8.0% over the next year. That's shaping up to be materially lower than the 15% growth forecast for the broader market.

In light of this, it's understandable that Scientex Berhad's P/E sits below the majority of other companies. It seems most investors are expecting to see limited future growth and are only willing to pay a reduced amount for the stock.

The Bottom Line On Scientex Berhad's P/E

It's argued the price-to-earnings ratio is an inferior measure of value within certain industries, but it can be a powerful business sentiment indicator.

We've established that Scientex Berhad maintains its low P/E on the weakness of its forecast growth being lower than the wider market, as expected. Right now shareholders are accepting the low P/E as they concede future earnings probably won't provide any pleasant surprises. It's hard to see the share price rising strongly in the near future under these circumstances.

It is also worth noting that we have found 2 warning signs for Scientex Berhad that you need to take into consideration.

Of course, you might find a fantastic investment by looking at a few good candidates. So take a peek at this free list of companies with a strong growth track record, trading on a low P/E.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About KLSE:SCIENTX

Scientex Berhad

An investment holding company, manufactures, markets, and sells stretch films and various flexible plastic packaging (FPP) products.

Undervalued with solid track record and pays a dividend.

Advertisement

Weekly Picks

LO
Lou_Basenese
CUE logo
Lou_Basenese on Cue Biopharma ·

Cue Biopharma (NASDAQ: CUE): The Scientist Behind Xolair Just Gave Cue a Next-Generation Shot at the Same Multi-Billion-Dollar Market

Fair Value:US$7057.9% undervalued
20 users have followed this narrative
0 users have commented on this narrative
5 users have liked this narrative
HE
HedgeY
ASTS logo
HedgeY on AST SpaceMobile ·

AST SpaceMobile: The Boldest Direct-to-Cell Bet in Public Markets

Fair Value:US$17044.9% undervalued
41 users have followed this narrative
0 users have commented on this narrative
12 users have liked this narrative
FU
ONTO logo
FundamentalFlow on Onto Innovation ·

Onto Innovation: The Advanced Packaging Chokepoint 51.3% undervalued intrinsic discount

Fair Value:US$38033.4% undervalued
26 users have followed this narrative
0 users have commented on this narrative
7 users have liked this narrative
MA
martinarauz
NU logo
martinarauz on Nu Holdings ·

Investment Analysis (May 2026)

Fair Value:US$22.7447.4% undervalued
58 users have followed this narrative
0 users have commented on this narrative
15 users have liked this narrative

Updated Narratives

EM
EmreDalgic_LongTermInvestor
IONQ logo
EmreDalgic_LongTermInvestor on IonQ ·

IonQ and Major Players Eyeing a $118.69 Fair Value Amid Quantum Growth

Fair Value:US$75.3524.6% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
RO
RockeTeller
GGD logo
RockeTeller on GoGold Resources ·

GoGold Resources, US$262M Cash Beats Los Ricos South Capex, Silver Giant Ready to be Built

Fair Value:CA$14.4179.0% undervalued
44 users have followed this narrative
4 users have commented on this narrative
1 users have liked this narrative
ED
ORCL logo
Edward_Sterling on Oracle ·

Oracle: The AI Capex Spree Is Consuming the Cash Machine

Fair Value:US$373.1342.7% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

MA
martinarauz
NU logo
martinarauz on Nu Holdings ·

Investment Analysis (May 2026)

Fair Value:US$22.7447.4% undervalued
58 users have followed this narrative
0 users have commented on this narrative
15 users have liked this narrative
CL
Clive_Thompson
TTWO logo
Clive_Thompson on Take-Two Interactive Software ·

Take-Two Interactive: The Calm Before the Storm NASDAQ: TTWO Last Price: $242.41 Date: May 15, 2026

Fair Value:US$276.9722.6% undervalued
57 users have followed this narrative
0 users have commented on this narrative
14 users have liked this narrative
NI
niteco
HON logo
niteco on Honeywell International ·

Honeywell - The Demand-Side of the AI Infrastructure

Fair Value:US$320.1933.2% undervalued
48 users have followed this narrative
0 users have commented on this narrative
19 users have liked this narrative